Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).

doi:10.3343/alm.2023.0356

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).

Annals of laboratory medicine - 1 Jul 2024

Jeong In Hwa, Yu SooHo, Kim Tae Yeul, Oh Soo-Young, Cho Duck

Abstract excerpt

Rh hemolytic disease of the fetus and newborn is a potential risk for D-negative mothers who produce anti-D during pregnancy, which can lead to morbidity and mortality in subsequent pregnancies. To prevent this hemolytic disease, Rho(D) immune globulin (RhIG) is generally administered to D-negative mothers without anti-D at 28 weeks of gestation and shortly after delivery. However, current guidelines suggest that...

Topics

Pregnancy
Infant, Newborn
Humans
Female
Rh-Hr Blood-Group System
Rho(D) Immune Globulin
Rh Isoimmunization
Genotype
Erythrocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 38384203
DOI: 10.3343/alm.2023.0356
PMCID: PMC10961623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics